Compare AXGN & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXGN | RQI |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2013 | N/A |
| Metric | AXGN | RQI |
|---|---|---|
| Price | $32.74 | $12.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $37.63 | N/A |
| AVG Volume (30 Days) | ★ 811.8K | 383.8K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $225,208,000.00 | N/A |
| Revenue This Year | $19.81 | N/A |
| Revenue Next Year | $16.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.21 | N/A |
| 52 Week Low | $9.22 | $10.39 |
| 52 Week High | $36.00 | $13.39 |
| Indicator | AXGN | RQI |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 48.70 |
| Support Level | $30.42 | $12.14 |
| Resistance Level | $34.26 | $13.38 |
| Average True Range (ATR) | 1.40 | 0.21 |
| MACD | 0.28 | -0.09 |
| Stochastic Oscillator | 77.93 | 34.95 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.